Impact BioMedical Inc.
IBO
$0.4324
$0.00741.74%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -737.99% | 579.03% | 7.80% | 22.11% | -6.28% |
| Total Depreciation and Amortization | 0.00% | 100.00% | -50.00% | 100.00% | 0.00% |
| Total Amortization of Deferred Charges | -0.72% | 0.36% | 0.00% | -0.36% | 0.00% |
| Total Other Non-Cash Items | 557.80% | -113,620.00% | 113.89% | -38.46% | -73.33% |
| Change in Net Operating Assets | -196.40% | -120.63% | -1,150.00% | -98.91% | 142.48% |
| Cash from Operations | 2.26% | -92.94% | 6.46% | -64.43% | 35.47% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 0.00% | -- | -- | -- |
| Cash from Investing | -100.00% | 0.00% | -- | -- | 200.00% |
| Total Debt Issued | 162.05% | -66.32% | -6.73% | 207.33% | -73.33% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -85.14% | 493.98% | -6.73% | 207.33% | -73.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.09% | -- | -100.00% | 100.50% | -201.01% |